4.7 Review

Primary Hemostasis Disorders as a Cause of Heavy Menstrual Bleeding in Women of Reproductive Age

Related references

Note: Only part of the references are listed.
Article Hematology

Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial

Margaret Ragni et al.

Summary: This study compared recombinant VWF with tranexamic acid for reducing heavy menstrual bleeding in patients with von Willebrand disease. The results showed that recombinant VWF was not superior to tranexamic acid in reducing heavy menstrual bleeding in patients with mild or moderate von Willebrand disease. The findings suggest that treatment options should be discussed with patients based on their preferences and experience.

LANCET HAEMATOLOGY (2023)

Article Hematology

Characterization of bleeding symptoms in Ehlers-Danlos syndrome

Mariia Kumskova et al.

Summary: This study used the ISTH-BAT to evaluate bleeding symptoms and their severity in 52 patients with different types of EDS. The results showed that EDS patients had significantly higher ISTH-BAT scores compared to the healthy control group. Bleeding symptoms included bruising, muscle hematomas, menorrhagia, epistaxis, bleeding from the oral cavity, and bleeding after tooth extraction. Some EDS patients experienced life-threatening or surgically treated menorrhagia.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2023)

Article Obstetrics & Gynecology

Use of the Levonorgestrel Intrauterine System to Treat Heavy Menstrual Bleeding in Adolescents and Young Adults with Inherited Bleeding Disorders and Ehlers-Danlos Syndrome

Patricia S. Huguelet et al.

Summary: This study investigated the use of the 52-mg levonorgestrel intrauterine system (LNG-IUS) in adolescents and young adults with a bleeding diathesis. The results showed that the LNG-IUS was effective in treating heavy menstrual bleeding and resulted in high rates of amenorrhea. However, there were higher rates of IUD expulsion within the first 30 days, but long-term continuation rates remained high.

JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY (2022)

Review Hematology

Gynecologic and obstetric management of women with von Willebrand disease: summary of 3 systematic reviews of the literature

Romina Brignardello-Petersen et al.

Summary: This study focuses on the impact of von Willebrand disease (VWD) on women and its management. The research findings suggest that desmopressin has a smaller effect on reducing menstrual blood loss compared to tranexamic acid (TxA). The evidence related to gynecologic and obstetric management of women with VWD is of low quality and further research is needed.

BLOOD ADVANCES (2022)

Review Hematology

Menstrual problems in chronic immune thrombocytopenia: A monthly challenge - a cohort study and review

Wobke E. M. van Dijk et al.

Summary: This cross-sectional study assessed menstrual problems in premenopausal chronic ITP women and found that the majority of patients experienced clinical menstrual problems. The study also found that the pictorial bleeding assessment calendar (PBAC) and menorrhagia multiattribute scale (MMAS) were associated with heavy menstrual bleeding, but not related to platelet count. Patients using levonorgestrel intrauterine device (LNG-IUD) had lower bleeding scores, and MMAS scores were correlated with fatigue.

BRITISH JOURNAL OF HAEMATOLOGY (2022)

Article Public, Environmental & Occupational Health

Impact of von Willebrand Disease on Women's Health Outcomes: A Matched Cohort Database Study

Katrina Wilcox Hagberg et al.

Summary: This retrospective cohort study revealed that von Willebrand disease has a significant impact on women's health, increasing the risk of hysterectomy and heavy menstrual bleeding.

JOURNAL OF WOMENS HEALTH (2022)

Article Hematology

Immune thrombocytopenia (ITP) World Impact Survey (iWISh): Patient and physician perceptions of diagnosis, signs and symptoms, and treatment

Nichola Cooper et al.

Summary: ITP patients and physicians largely align in terms of diagnosis, symptoms, and treatment use, with certain differences noted in specific areas such as fatigue. Understanding the emotional and clinical toll of ITP on the patient will facilitate shared decision-making and appropriate treatment selection based on disease stage.

AMERICAN JOURNAL OF HEMATOLOGY (2021)

Article Hematology

ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease

Paula D. James et al.

Summary: These evidence-based guidelines on von Willebrand disease (VWD) provide 11 key recommendations for clinicians and patients, covering various aspects of VWD diagnosis, including the use of bleeding-assessment tools, diagnostic assays, laboratory cutoffs, and genetic testing versus phenotypic assays. Future critical research priorities are also identified.

BLOOD ADVANCES (2021)

Article Hematology

ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease

Nathan T. Connell et al.

Summary: These evidence-based guidelines from ASH, ISTH, NHF, and WFH are intended to support patients, clinicians, and health care professionals in their decisions about management of VWD. The panel agreed on 12 recommendations and outlined future research priorities.

BLOOD ADVANCES (2021)

Review Obstetrics & Gynecology

The presentation and outcomes of Hermansky-Pudlak syndrome in obstetrics and gynecological settings: A systematic review

Deborah Obeng-Tuudah et al.

Summary: Hermansky-Pudlak syndrome (HPS) is a rare autosomal-recessive disorder characterized by bleeding diathesis and oculocutaneous albinism in women. Management strategies for women with HPS include desmopressin and platelet transfusions, with close collaboration between obstetrics and gynecology and hematology teams recommended. Heavy menstrual bleeding and post-partum hemorrhage may lead to diagnosis of HPS in affected women.

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2021)

Review Rheumatology

The Beighton Score as a measure of generalised joint hypermobility

Sabeeha Malek et al.

Summary: The Beighton Score is a standard method for assessing joint hypermobility, but its ability to accurately reflect generalized joint hypermobility is controversial. Clinician judgement should play a key role in identifying or excluding joint hypermobility, rather than relying solely on the Beighton Score.

RHEUMATOLOGY INTERNATIONAL (2021)

Article Oncology

Von Willebrand Disease Current Status of Diagnosis and Management

Angela C. Weyand et al.

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2021)

Article Obstetrics & Gynecology

Gynecologic Management of Pediatric and Adolescent Patients with Ehlers-Danlos Syndrome

Angela Marie C. Hernandez et al.

JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY (2020)

Review Hematology

Management of immune thrombocytopenia in women: current standards and special considerations

Francesco Rodeghiero et al.

EXPERT REVIEW OF HEMATOLOGY (2020)

Article Medicine, General & Internal

Glanzmann's thrombasthenia: a rare bleeding disorder in a Nigerian girl

Osita U. Ezenwosu et al.

AFRICAN HEALTH SCIENCES (2020)

Article Oncology

Characterizing adolescents with heavy menstrual bleeding and generalized joint hypermobility

Nicole E. Kendel et al.

PEDIATRIC BLOOD & CANCER (2019)

Article Hematology

Bleeding assessment in female patients with the Hermansky-Pudlak syndrome-A case series

Joel Rivera-Concepcion et al.

EUROPEAN JOURNAL OF HAEMATOLOGY (2019)

Article Hematology

American Society of Hematology 2019 guidelines for immune thrombocytopenia

Cindy Neunert et al.

BLOOD ADVANCES (2019)

Article Hematology

Hemostatic abnormalities in patients with Ehlers-Danlos syndrome

A. Artoni et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2018)

Article Genetics & Heredity

The 2017 International Classification of the Ehlers-Danlos Syndromes

Fransiska Malfait et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS (2017)

Review Obstetrics & Gynecology

Heavy Menstrual Bleeding as a Common Presenting Symptom of Rare Platelet Disorders: Illustrative Case Examples

Madhvi Rajpurkar et al.

JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY (2016)

Review Medicine, General & Internal

Von Willebrand's Disease

Frank W. G. Leebeek et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Review Hematology

New Insights Into the Treatment of Glanzmann Thrombasthenia

Man-Chiu Poon et al.

TRANSFUSION MEDICINE REVIEWS (2016)

Article Education, Scientific Disciplines

Heavy menstrual bleeding: work-up and management

Andra H. James

HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2016)

Review Hematology

Update on von Willebrand factor multimers: focus on high-molecular-weight multimers and their role in hemostasis

Marcus Stockschlaeder et al.

BLOOD COAGULATION & FIBRINOLYSIS (2014)

Article Obstetrics & Gynecology

ACOG Committee Opinion No. 451: Von Willebrand Disease in Women

OBSTETRICS AND GYNECOLOGY (2014)

Review Hematology

Molecular determinants of platelet delta storage pool deficiencies: an update

Julien Masliah-Planchon et al.

BRITISH JOURNAL OF HAEMATOLOGY (2013)

Article Oncology

Immune Thrombocytopenia

Gaurav Kistangari et al.

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2013)

Article Rheumatology

Joint Hypermobility Syndrome

Asma Fikree et al.

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2013)

Review Pediatrics

Clinical practice

C. Heleen van Ommen et al.

EUROPEAN JOURNAL OF PEDIATRICS (2012)

Article Hematology

Treatment of inherited platelet disorders

U. Seligsohn

HAEMOPHILIA (2012)

Article Hematology

Intensive Menstrual Bleeding Successfully Treated With Recombinant Factor VIIa in Glanzmann Thrombasthenia

Yasemin Isik Balci et al.

CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2011)

Article Genetics & Heredity

von Willebrand disease

Paula D. James et al.

GENETICS IN MEDICINE (2011)

Letter Hematology

An unexpected transmission of von Willebrand disease type 3: the first case of maternal uniparental disomy 12

Pierre Boisseau et al.

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)

Editorial Material Obstetrics & Gynecology

FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age

Malcolm G. Munro et al.

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2011)

Article Hematology

Gynaecological and obstetric bleeding in moderate and severe von Willebrand disease

Eva M. de Wee et al.

THROMBOSIS AND HAEMOSTASIS (2011)

Review Medical Laboratory Technology

Glanzmann thrombasthenia: An update

Massimo Franchini et al.

CLINICA CHIMICA ACTA (2010)

Article Obstetrics & Gynecology

Obstetric Management of Adolescents with Bleeding Disorders

Andra H. James

JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY (2010)

Article Hematology

Platelet function defects

D. Simon et al.

HAEMOPHILIA (2008)

Review Genetics & Heredity

Glanzmann thrombasthenia

Alan T. Nurden

ORPHANET JOURNAL OF RARE DISEASES (2006)

Article Obstetrics & Gynecology

von Willebrand disease in women with menorrhagia: a systematic review

M Shankar et al.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2004)

Article Obstetrics & Gynecology

The use of levonorgestrel-releasing intrauterine system for treatment of menorrhagia in women with inherited bleeding disorders

CEC Kingman et al.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2004)

Article Hematology

Presentation and pattern of symptoms in 382 patients with Glanzmann thrombasthenia in Iran

G Toogeh et al.

AMERICAN JOURNAL OF HEMATOLOGY (2004)

Review Medicine, General & Internal

Medical progress: Immune thrombocytopenic purpura.

DB Cines et al.

NEW ENGLAND JOURNAL OF MEDICINE (2002)

Article Obstetrics & Gynecology

Severe menorrhagia due to Glanzmann thrombasthenia treated with hydrothermal ablation

JS Jimenez et al.

JOURNAL OF THE AMERICAN ASSOCIATION OF GYNECOLOGIC LAPAROSCOPISTS (2000)